Can placement of a new dialysis (peritoneal dialysis or hemodialysis) catheter lead to an elevation in creatinine levels, indicating impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dialysis Catheter Placement Does Not Directly Cause Creatinine Elevation

The placement of a new dialysis catheter itself does not lead to elevation in creatinine levels. Creatinine elevation reflects impaired kidney function or acute kidney injury, not the mechanical act of catheter insertion. However, complications associated with catheter placement or the clinical context surrounding it may indirectly affect renal function.

Understanding the Relationship Between Catheter Placement and Creatinine

Direct Effects: None Expected

  • Catheter insertion is a vascular access procedure that does not directly injure kidney tissue or impair glomerular filtration 1, 2.
  • For peritoneal dialysis catheters, placement involves accessing the peritoneal cavity, not the kidneys themselves, and should not affect creatinine production or clearance 1, 2.
  • For hemodialysis catheters, placement in central veins (jugular, femoral, or subclavian) provides vascular access but does not mechanically damage renal parenchyma 3, 4.

Indirect Mechanisms That May Affect Creatinine

Several clinical scenarios surrounding catheter placement could lead to creatinine changes, though these are complications rather than direct effects:

Hemodynamic Instability During Placement

  • Hypotension, bleeding, or volume depletion during catheter insertion can reduce renal perfusion pressure and cause acute kidney injury 1.
  • In patients with advanced heart failure requiring dialysis access, hemodynamic disturbances from the procedure itself or from rapid ultrafiltration can worsen kidney function 1.
  • The American Heart Association emphasizes that maintaining adequate mean arterial pressure and reducing central venous pressure are critical to preserving kidney perfusion in vulnerable patients 1.

Contrast-Induced Nephropathy (If Imaging Used)

  • If fluoroscopy or contrast-enhanced imaging is used during catheter placement, contrast-induced nephropathy can cause creatinine elevation 1, 5.
  • The American College of Cardiology recommends maintaining contrast volume to creatinine clearance ratio <3.7 to minimize nephropathy risk 1, 5.
  • For peritoneal dialysis patients, hydration with isotonic saline before, during, and after contrast exposure is recommended, though peritoneal dialysis itself cannot prevent contrast-induced damage as it occurs rapidly after administration 5.

Infection and Sepsis

  • Catheter-related bloodstream infections can lead to sepsis-induced acute kidney injury with subsequent creatinine elevation 1.
  • The risk of infection is particularly elevated with hemodialysis catheters, especially non-tunneled temporary catheters 1, 6.
  • Proper sterile technique during insertion and use of prophylactic antibiotics reduce infection risk 2, 4.

Underlying Clinical Context

  • Patients requiring new dialysis catheter placement typically have advanced kidney disease, and creatinine elevation may reflect disease progression rather than catheter placement 1.
  • In advanced heart failure patients, rises in creatinine during decongestion therapy do not necessarily indicate kidney injury and often reverse after hospitalization 1.

Monitoring After Catheter Placement

Expected Creatinine Trajectory

  • In patients starting peritoneal dialysis, baseline 24-hour urine collections for creatinine clearance should be obtained to establish residual kidney function 1.
  • Creatinine levels should be monitored to assess dialysis adequacy, not as an indicator of catheter-related injury 1, 2.
  • For patients exposed to contrast during placement, renal function should be monitored at 7 days and 4 weeks to detect potential nephropathy 5.

When to Investigate Creatinine Changes

  • A change in daily creatinine excretion (in urine plus dialysate) of >15% from baseline warrants investigation for noncompliance, collection errors, or altered peritoneal transport function 1.
  • Acute creatinine elevation after catheter placement should prompt evaluation for procedural complications (bleeding, hypotension), infection, or contrast exposure rather than assuming the catheter itself caused kidney injury 1, 2.

Common Pitfalls to Avoid

  • Do not attribute creatinine elevation to catheter placement without investigating other causes such as hemodynamic instability, infection, contrast exposure, or disease progression 1, 2.
  • Avoid subclavian vein catheter placement as it increases risk of central vein stenosis; ultrasound-guided internal jugular or femoral access is preferred 4.
  • Do not exchange a dysfunctional catheter over a guidewire; replace it at a new site to reduce infection risk 4.
  • For peritoneal dialysis, waiting 10-14 days after catheter placement before initiating full-volume exchanges reduces risk of leaks and mechanical complications, though low-volume supine dialysis can be started earlier if needed 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults).

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2021

Research

Dialysis Catheter Placement in Patients With Exhausted Access.

Techniques in vascular and interventional radiology, 2017

Guideline

Prevention of Contrast-Induced Nephropathy in Peritoneal Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.